Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response.

@article{Handman1995ProtectiveVW,
  title={Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response.},
  author={Emanuela Handman and Fr. Symons and Tracey M. Baldwin and Joan M. Curtis and Jean Pierre Y Scheerlinck},
  journal={Infection and immunity},
  year={1995},
  volume={63 11},
  pages={
          4261-7
        }
}

• Emanuela Handman, Fr. Symons, +2 authors Jean Pierre Y Scheerlinck
• Published 1995 in Infection and immunity

Leishmania major promastigote surface antigen-2 complex (PSA-2) comprises a family of three similar but distinct polypeptides. The three PSA-2 polypeptides were purified from cultured promastigotes by a combination of detergent phase separation and monoclonal antibody affinity chromatography. Intraperitoneal vaccination of C3H/He mice with PSA-2 with Corynebacterium parvum as an adjuvant resulted in complete protection from lesion development after challenge infection with virulent L. major… CONTINUE READING

Save to Library

Create Alert

Cite

View on PubMed